Micro
Aftermath
Archived
CRM $25 miliardi accelerated share repurchase
Attività in calo — la narrativa perde rilevanza.
Punteggio
0,3
Velocità
▲ 0,0
Articoli
12
Fonti
3
Cronologia del Sentiment
Performance Settoriale
Performance del Titolo
Cronologia degli Eventi
Mar 25, 2026
ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement
Bullish
Mar 22, 2026
Is Salesforce a good long-term investment? Its buy-and-hold prospects explained
Neutral
Articoli Correlati
CrowdStrike Boosts Share Repurchase Program By $500 Mln To $1.5 Bln
Nasdaq
·
Apr 06, 2026
ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement
Yahoo Finance
·
Mar 25, 2026
What Salesforce, Inc. (CRM)’s FY27 Strategy Signals
Yahoo Finance
·
Mar 23, 2026
Is Salesforce a good long-term investment? Its buy-and-hold prospects explained
Yahoo Finance
·
Mar 22, 2026
A $50 Billion Buyback Is Raising Questions About Salesforce’s Growth Story
Yahoo Finance
·
Mar 21, 2026
Salesforce issues $25 billion in debt to buy back stock. Should we be concerned?
CNBC
·
Mar 20, 2026
A $25 Billion Catalyst to Watch Salesforce Stock Here
Yahoo Finance
·
Mar 20, 2026
The Artificial Intelligence (AI) Stock That Could Redefine Its Industry by the End of 2026
Nasdaq
·
Mar 20, 2026
Salesforce (CRM) Announces Commencement of Largest-Ever $25 Billion Accelerated Share Repurchase
Yahoo Finance
·
Mar 20, 2026